References

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

10.1016/j.vaccine.2015.07.035 · 2015 · External reference

Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century

10.1016/j.eclinm.2019.10.001 · 2019 · External reference

Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases

10.1002/hep.31065 · 2020 · External reference

Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome

10.1002/hep.32572 · 2022 · External reference

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis

10.1016/j.jhep.2022.03.040 · 2022 · External reference

Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: a population-based pharmacovigilance analysis

10.3389/fphar.2023.1100617 · 2023 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Virtual research designs and IRB requirements: clarifying what truly needs ethics approval

10.23736/s0026-4806.26.09862-9 · 2026 · External reference

Unresolved reference

External reference

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

10.1016/j.vaccine.2014.07.073 · 2014 · External reference

First month of COVID-19 vaccine safety monitoring - United States, December 14, 2020-January 13, 2021

10.15585/mmwr.mm7008e3 · 2021 · External reference

Sex differences in immune responses

10.1038/nri.2016.90 · 2016 · External reference

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents

2005 · External reference

Autoimmune hepatitis after COVID-19 vaccination

10.3389/fimmu.2022.1035073 · 2022 · External reference

Auto-immune hepatitis following COVID vaccination

10.1016/j.jaut.2021.102688 · 2021 · External reference

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group

10.1016/j.jpeds.2005.12.051 · 2006 · External reference

Developmental pharmacology--drug disposition, action, and therapy in infants and children

10.1056/nejmra035092 · 2003 · External reference

Immune-mediated adverse reactions to vaccines

10.1111/bcp.14112 · 2019 · External reference

Immune-mediated liver injury following COVID-19 vaccination

10.5501/wjv.v12.i2.100 · 2023 · External reference

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

10.1016/s1473-3099(22)00054-8 · 2022 · External reference

Epidemiology in the United Kingdom of adverse drug reactions from non-steroidal anti-inflammatory drugs

10.1007/978-94-010-9772-7_2 · 1987 · External reference